JCS/JSCS 2020 Guideline on Diagnosis and Management of Cardiovascular Sequelae in Kawasaki Disease

Abstract

As a summary of this guideline, Table 21 shows the frequency of each examination, treatment, and lifestyle guidance according to the severity classification of KD. Authors would be pleased if it could be used as a reference for medical staff who handle the remote stage of KD. On the other hand, the higher the severity, the more likely it is that various disorders will be complicated, and specialists are required to manage each case individually. Keeping in mind that the policy shown in this guideline is general, authors would like readers to deal with each case with the best policy. Most of the long-term treatment and management of KD still have a low level of evidence, and the treatments that could show strong recommendation level in this guideline are very limited. Authors would like to emphasize that the accumulation of evidence is urgent in the future.